Published in J Geriatr Psychiatry Neurol on July 12, 1990
Late-life onset of panic disorder with agoraphobia in three patients. Am J Psychiatry (1989) 2.10
Genetic linkage of Werner's syndrome to five markers on chromosome 8. Nature (1992) 1.37
Letter: Levulinic esters. An alcohol protecting group applicable to some nucleosides. J Am Chem Soc (1975) 1.31
In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells. Anticancer Res (2009) 0.92
Cochlear action potentials in experimentally induced hypothyroidism in guinea pigs. Acta Otolaryngol Suppl (1975) 0.91
Changes in radical prostatectomy and radiation therapy rates for African Americans and whites. J Natl Med Assoc (2000) 0.90
Periarticular inflammation, bilateral hilar adenopathy and a sarcoid reaction. Arthritis Rheum (1970) 0.89
Successful streptokinase therapy for catheter-induced subclavian vein thrombosis. Arch Intern Med (1980) 0.87
Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins. Am J Reprod Immunol Microbiol (1985) 0.87
A genetic analysis of the Werner syndrome region on human chromosome 8p. Genomics (1993) 0.87
Renal cell carcinoma: the size variable. J Surg Oncol (1993) 0.86
Solitary renal calix. JAMA (1978) 0.83
A pseudoepidemic of recent tuberculin test conversions caused by a dosing error. Clin Infect Dis (1996) 0.82
An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer. J Surg Oncol (1998) 0.82
The proliferative response of hela cells to 2-deoxy-D-glucose under hypoxic or anoxic conditions: an analogue for studying some properties of in vivo solid cancers. Anticancer Res (2007) 0.81
An evaluation of five tests to diagnose prostate cancer. Prog Clin Biol Res (1987) 0.81
Malacoplakia of the prostate. South Med J (1977) 0.81
Report of 337 patients with renal cell carcinoma emphasizing 110 with stage IV disease and review of the literature. J Surg Oncol (1997) 0.81
Bone scan as a stratification variable in advanced prostate cancer. Cancer (1991) 0.80
Retention impairment produced by unilateral amygdala implantation: reduction by posttrial amygdala stimulation. Behav Biol (1978) 0.79
Combination therapy using polyamine synthesis inhibitor alpha-difluoromethylornithine and adriamycin in treatment of rats carrying the Dunning R3327 MAT-LyLu prostatic adenocarcinoma. Prostate (1987) 0.79
An immunohistologic characterization of human prostatic atypical hyperplasia. Urol Res (1990) 0.79
Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model. Methods Find Exp Clin Pharmacol (1998) 0.79
A qualitative analysis of acidic proteins associated with regressing, growing, or dividing rat ventral prostate cells. Prostate (1983) 0.79
Normoxic or hypoxic CD44/CD41 a₂ B₁ integrin-positive prostate PC3 cell side fractions and cancer stem cells. Med Oncol (2013) 0.79
Relationship of arachidonic acid metabolism to indomethacin-sensitive immunoregulatory function and lymphocyte PGE sensitivity in peripheral blood mononuclear cells of disseminated solid tumor cancer patients. J Immunopharmacol (1984) 0.78
Effect of cyclophosphamide on leukocytic subset distributions in rats carrying the Dunning R3327-MAT-LyLu prostatic adenocarcinoma. Prostate (1987) 0.78
The effect of normoxia and hypoxia on a prostate (PC-3) CD44/CD41 cell side fraction. Anticancer Res (2011) 0.78
Videotape tic counts in the assessment of Tourette's syndrome: stability, reliability, and validity. J Am Acad Child Adolesc Psychiatry (1994) 0.78
The effect of androgen deprivation on malignant and benign prostate tissue. Med Oncol (1998) 0.78
Are cancer stem cells concentrated in more alkaline hypoxic regions of tumors? Med Hypotheses (2009) 0.78
To what extent are the "sets" of biologic properties expressed by hypoxic cancer cells and by cancer "stem" cells equivalent, intersecting, disjoint or complementary? Some implications for the design of cancer therapies. Med Hypotheses (2006) 0.77
Retention deficit for avoidance training in hypophysectomized rats: time-dependent enhancement of retention performance with post-training ACTH injections. Horm Behav (1977) 0.77
Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus. Lupus (2007) 0.77
Does homeobox-related "positional" genomic information contribute to implantation of metastatic cancer cells at non-random sites? Anticancer Res (2007) 0.77
Time-dependent post-trial changes in the localization of amnestic electrical stimulation sites within the amygdala in rats. Behav Biol (1977) 0.77
Antitumor effect of CPT-11, a new derivative of camptothecin, against human prostate cancer (PC-3) in vitro and prostate rat tumor (AT-3) in vivo. Methods Find Exp Clin Pharmacol (1996) 0.77
The instability of membrane markers expressed by human monocytes and macrophages in culture. Immunobiology (1983) 0.77
Do intra-tumor alkaline micro-regions represent additional therapeutically privileged sites? Med Hypotheses (2008) 0.76
Influences of pituitary-adrenal hormones on kindling. Brain Res (1979) 0.76
Effect of early and delayed difluoromethylornithine pretreatment upon cyclophosphamide chemotherapy. Clin Physiol Biochem (1990) 0.76
Impaired retention of visual discriminated escape training produced by subseizure amygdala stimulation. Brain Res (1976) 0.76
Staging and survival of patients with renal cell carcinoma. Semin Surg Oncol (1994) 0.75
Renal cell carcinoma: comparison of the TNM and Robson stage groupings. J Surg Oncol (1995) 0.75
In-vivo expression of a C-type RNA virus in rat ventral prostate epithelial cells. Biochem Biophys Res Commun (1979) 0.75
Percutaneous endoscopic treatment of bleeding gastric ulcers. JSLS (1999) 0.75
Rat ventral prostate cell lysis at 2 degrees C. Clin Physiol Biochem (1986) 0.75
Characterization of cellular infiltrates in the rat urinary bladder following BCG and thiotepa intravesical therapy. J Surg Oncol (1991) 0.75
AMS performance management system "passes the test". Provider (1987) 0.75
Impairment of retention of avoidance responses in rats by posttraining diethyldithiocarbamate. Psychopharmacology (Berl) (1977) 0.75
Effect of sodium salicylate on hamster cells in vitro. J Pharm Sci (1976) 0.75
BCG in management of superficial bladder cancer. Urology (1987) 0.75
Early effects of castration and replacement of androgen on the expression of retrovirus-like particles in rat ventral prostate epithelial cells. Proc Soc Exp Biol Med (1982) 0.75
Differential responsivity of verbal and visual recognition memory to physostigmine and ACTH. Biol Psychiatry (1986) 0.75
BCG in management of transitional cell carcinoma invasive to prostate. Urology (1989) 0.75
Cytoreductive surgery impedes metastasis and enhances the immune response: a preliminary report. J Surg Oncol (1991) 0.75
Mithramycin impairs the release of 45Ca from bone induced by prostaglandin E2 or multiple myeloma sera. Implications for a novel means of local tumor control. Oncology (1982) 0.75
Immunopriming of tumor infiltrating lymphocytes with neoadjuvant cyclophosphamide. Immunol Invest (1993) 0.75
In vitro stimulation by prostate extracts of rat ventral prostate stromal and epithelial cell division. Prostate (1986) 0.75
The effect of hormone therapy on peripheral blood leukocytic subset distribution in stage D prostatic cancer patients. Urol Res (1985) 0.75
Phenytoin removal by plasmapheresis in thrombotic thrombocytopenic purpura. Clin Pharmacol Ther (1982) 0.75
The effect of BCG on thoracic duct lymphocytes. Immunol Invest (1992) 0.75
Methods of early diagnosis in genitourinary cancer. Cancer (1987) 0.75
Bilateral orchiectomy in the management of stage D-2 prostate cancer. Int Surg (1993) 0.75
A profile of the San Francisco Bisexual Center. J Homosex (1985) 0.75
Acute changes in U937 nuclear Ca2+ preceding type 1 "apoptotic" programmed cell death due to MK 886. Anticancer Res (2004) 0.75
Leukocytic subset distributions of spleen cells obtained from rats bearing variants of the Dunning prostatic adenocarcinoma. J Urol (1986) 0.75
Bropirimine as neoadjuvant therapy decreases residual disease and expression of markers PCNA and TGF-beta 1 in a rat orthotopic prostate adenocarcinoma. Methods Find Exp Clin Pharmacol (1997) 0.75
Paclitaxel, bropirimine and linomide: effect on growth inhibition in a murine prostate cancer model by different growth regulatory mechanisms. Methods Find Exp Clin Pharmacol (1998) 0.75
Suspected arsine poisoning during the restoration of a large cyclorama painting. Am Ind Hyg Assoc J (1981) 0.75
Adrenal gland in major depression: enlarged capacity or enhanced sensitivity? Arch Gen Psychiatry (1988) 0.75
Definition of the pulmonary antibody response to ovalbumin following local challenge in systemically immunized rats. Proc Soc Exp Biol Med (1988) 0.75
Nuclear protein synthesis at permissive and non-permissive temperatures in a Chinese hamster ovary cell line with a temperature-sensitive defect in cytoplasmic non-mitochondrial protein synthesis. Exp Cell Res (1979) 0.75
Suramin as adjuvant therapy with radical prostatectomy. Prostate (1996) 0.75
Lymphocyte subsets in urologic cancer patients. Urol Res (1987) 0.75
Effects of castration and replacement of androgen on the separation of rat ventral prostate cells by Ficoll gradient centrifugation. Clin Physiol Biochem (1983) 0.75
The effect of low-dose cyclophosphamide and immunologic exposure upon growth of established Dunning R-3327-G subline rat prostate adenocarcinomas. Prostate (1985) 0.75
Evaluation of cytokeratin markers to differentiate between benign and malignant prostatic tissue. J Surg Oncol (1989) 0.75
Survival of Mexican-American males with seminoma. Rev Invest Clin (1997) 0.75
Hormonal influences on seizure kindling: the effects of post-stimulation ACTH or cortisone injections. Brain Res (1982) 0.75
Isolation of viable rat ventral prostate epithelial and nonepithelial cells. Endocrinology (1980) 0.75
BCG in the management of superficial bladder cancer. Prog Clin Biol Res (1989) 0.75
Administration of recombinant tumor necrosis factor to rats bearing the Dunning R3327 MAT-LyLu prostatic adenocarcinoma. Clin Physiol Biochem (1987) 0.75
Microsurgical approach to the abdominal thoracic duct in the rat: considerations in the collection of lymphocytes. Microsurgery (1992) 0.75
Disparate forms of MK 886-induced programmed death in BCL-2 (+) blood and BCL-2 (-) solid cancer cells and a putative "nuclear" Ca2+ channel: "soil" trumps "seed"? Med Hypotheses (2005) 0.75
A computerized surveillance data management system using Epi Info. AAOHN J (1996) 0.75
Strongyloidiasis associated with ulcerative colitis. J Med Soc N J (1970) 0.75
The differences between treatment and prevention in mental health. Hosp Community Psychiatry (1982) 0.75
Prostatic ultrasound in follow-up of prostatic disease. Urology (1988) 0.75
Cortisol response to ACTH infusion in depressed patients: comparison with age-, sex-, and weight-matched normal subjects. Psychoneuroendocrinology (1988) 0.75
Reactive oxygen species and redox-induced programmed cell death due to MK 886: cells ("soil") "trump" agent ("seed"). In Vivo (2005) 0.75
Immunoregulatory markers in rats carrying Dunning R3327 H, G, or MAT-LyLu prostatic adenocarcinoma variants. Cancer Res (1987) 0.75
Adherent spleen cell production of E series prostaglandins in rats bearing variants of the R3327 Dunning prostatic adenocarcinoma: effect of cyclophosphamide. J Immunopharmacol (1986) 0.75